U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million ...

World Development Report 2022: FINANCE for an Equitable RecoveryToday’s unprecedented growth of data and their ubiquity in our lives are signs that the data revolution is transforming the world. And ...